Self-Help Interventions for Crohn's Disease
(EMPOWER-IBD Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how different self-help tools can empower people with Crohn's disease and other inflammatory bowel diseases to better manage their condition. It aims to identify which tools, such as a book, an app, a help center, or a peer mentor, can reduce the daily challenges caused by IBD. Participants will be divided into groups to test these resources, collectively called EMPOWER-IBD Interventions. Adults who have experienced moderate-to-severe daily difficulties due to IBD and can use smartphone apps might be a good fit. As an unphased trial, this study offers a unique opportunity for patients to contribute to innovative approaches in managing IBD.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems to focus on self-help resources rather than medication changes.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that the self-help tools in this trial are generally safe for people with Crohn's disease.
The Power of Two (PEER) program, a peer mentoring service run by the Crohn's & Colitis Foundation, has no evidence of harmful effects. It emphasizes support and connection between patients, making it well-received.
The IBD Help Center (HELP), another resource from the Crohn's & Colitis Foundation, provides information and guidance without any known safety concerns.
The "Coping with Crohn's and Colitis" workbook employs cognitive behavioral therapy (CBT). Studies have shown that CBT can improve mental health in people with IBD and is considered safe.
Lastly, the My IBD Care app helps users track symptoms and manage their condition. It has received positive reviews for quality and has not been linked to any safety issues.
Overall, these tools are non-invasive and focus on support and education. They aim to help manage the condition rather than directly treat it, making them low-risk in terms of safety.12345Why are researchers excited about this trial?
Researchers are excited about the EMPOWER-IBD interventions because they offer a fresh approach to managing Crohn's Disease through self-help techniques, rather than traditional medication alone. Unlike typical treatments that focus directly on inflammation, these interventions emphasize psychological and social support. For instance, the Power of Two (PEER) program provides one-on-one peer mentoring, while the IBD Help Center offers personalized guidance via various communication methods. Additionally, the integration of cognitive behavioral therapy (CBT) through a specialized workbook and the use of the My IBD Care app for symptom tracking and self-paced behavioral change set these treatments apart by empowering patients to take an active role in managing their condition.
What evidence suggests that this trial's treatments could be effective for reducing IBD-related disability?
This trial will evaluate various self-help interventions for Crohn's Disease. Research has shown that peer support programs, such as the Power of Two (PEER), one of the interventions in this trial, can help people with inflammatory bowel disease (IBD) manage their condition better and build emotional strength. Another intervention, the IBD Help Center (HELP), reduced urgent care visits by 51% with its Urgent Care Toolkit, highlighting the benefits of access to helpful information and resources. Cognitive Behavioral Therapy (CBT) for IBD, featured in the "Coping with Crohn's and Colitis" workbook, is also being tested in this trial and has enhanced quality of life while reducing anxiety and depression in patients. Additionally, the My IBD Care app, another intervention in this trial, assists users in managing symptoms and tracking medical information, earning high ratings for quality and usefulness. Together, these tools and programs show promise in helping individuals handle the challenges associated with IBD.13678
Are You a Good Fit for This Trial?
This trial is for adults over 18 with moderate-to-severe IBD-related disability (score > 35). Participants must be able to consent, complete surveys, and join focus groups in English. It's not for those with low/no disability, unwilling to engage in interventions or unable to download apps due to language limitations.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are randomized to one of 16 arms to receive a combination of four multimodal behavioral interventions, including a book, smart app, help center, and peer mentor, to test their clinical effectiveness in reducing IBD-related disability and improving self-efficacy.
Follow-up
Participants are monitored for changes in IBD self-efficacy and IBD-related disability after the intervention.
What Are the Treatments Tested in This Trial?
Interventions
- EMPOWER-IBD Interventions
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Pennsylvania
Lead Sponsor